Click to Enlarge Market Cap: $45M
Description from Yahoo! Finance
Galena Biopharma (NASDAQ:GALE), a biotechnology company, engages in discovering, developing and commercializing innovative therapies addressing unmet medical needs using targeted bio therapeutics. The company is pursuing the development of cancer therapeutics using peptide-based immunotherapeutics, including its main product candidate, NeuVax (E75) for the treatment of various cancers.
Click to Enlarge Technical Analysis
The stock is making a series of higher highs and higher lows and currently is forming a bull flag that should resolve to the upside on a trade through $1.15.
As of this writing, Serge Berger did not hold a position in any of the aforementioned securities.